ULURU Inc. Reports Third Quarter 2009 Financial Results
11/17/2009 11:04:50 AM
More...
|
ULURU Inc. to Raise $1.5 Million in Registered Direct Offering
11/12/2009 10:33:50 AM
More...
|
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
11/3/2009 10:48:16 AM
More...
|
ULURU Inc. Announces Poster Presentation of Dr. Gregory Bohn
10/23/2009 11:43:09 AM
More...
|
ULURU Inc. Announces Extensive Clinical Evidence Presented at the 24th Annual 'Clinical Symposium on Advances in Skin and Wound Care'-Symposium to Feature 16 Poster Presentations on the Clinical Results of Altrazeal(TM)
10/21/2009 9:50:39 AM
More...
|
ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
7/30/2009 9:45:30 AM
More...
|
ULURU Inc. Announces Status of York Note Receivable
7/28/2009 9:41:37 AM
More...
|
ULURU Inc. Restructured Operations to Conserve Cash to Further the Company's Business
6/30/2009 7:17:16 AM
More...
|
ULURU Inc. Discussions to Acquire York Pharma PLC (YRK) Terminated
6/25/2009 6:50:31 AM
More...
|
ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update
5/14/2009 9:42:10 AM
More...
|
|